Your browser doesn't support javascript.
loading
What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?
Stiefel, Rahel; Lehmann, Kuno; Winder, Thomas; Siebenhüner, Alexander R.
Afiliação
  • Stiefel R; Medical Oncology and Hematology, Triemli Hospital Zurich, Zurich, Switzerland.
  • Lehmann K; Department of Surgery and Transplantation, University Hospital and University of Zurich, Zurich, Switzerland.
  • Winder T; Internal Medicine II, Hematology, Oncology and Gastroenterology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria.
  • Siebenhüner AR; University of Zurich, Zurich, Switzerland.
BMC Cancer ; 23(1): 148, 2023 Feb 13.
Article em En | MEDLINE | ID: mdl-36782152
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Gástricas / Tumores Neuroendócrinos / Neoplasias Intestinais Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Gástricas / Tumores Neuroendócrinos / Neoplasias Intestinais Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça